Use of botulinum toxin for treating cardiovascular diseases

Details for Australian Patent Application No. 2007200658 (hide)

Owner Allergan, Inc.

Inventors Not Given

Agent Davies Collison Cave

Pub. Number AU-A-2007200658

Parent 2003220511

Filing date 16 February 2007

Wipo publication date 8 March 2007

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61L 31/04 (2006.01) Materials for other surgical articles - Macromolecular materials

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

1 March 2007 Complete Application Filed

8 March 2007 Application Open to Public Inspection

  Published as AU-A-2007200658

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007200659-Cascade Solar Cell with Amorphous Silicon-based Solar Cell

2007200657-Disruptiv Clothing Company